Takeda Pharmaceutical (TSE:4502) is back in focus after recent trading, with the stock closing at ¥5,108 and showing mixed short term moves, including a decline over the past 3 months and over the ...

Plaintiffs allege Takeda and Sucampo’s 2014 settlement with Par over generic Amitiza patent litigation was anticompetitive.

The pharmaceutical company is cutting thousands of jobs as it restructures amid pressure from antitrust allegations in the ...

Takeda plans to appeal after a federal jury found it liable in a landmark pay-for-delay antitrust case and ordered the ...

Far fewer companies are letting employees go so far in 2026 compared to 2025, but the number of people affected is trending ...

The board of Irish pharmaceutical company Shire will recommend a new £46 billion ($64 billion) takeover bid by Japanese firm ...

Takeda confirmed it would appeal the outcome, stating that the case “lacks merit”.

Massachusetts' largest pharmaceutical company just got hit with an $885 million verdict — but the final bill may actually top ...

A federal jury found Takeda Pharmaceuticals Co. Ltd. liable for violating antitrust law by delaying the generic version of its branded Amitiza drug through an illegal agreement with a competitor, ...

A U.S. federal jury has ordered Japan-based Takeda Pharmaceutical to pay approximately $885 million in damages after finding the company liable for delaying the release of a generic version of its ...

Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week ...